ZKY001 eye drops

DRUG2 trials

Sponsors

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Conditions

Corneal DiseasesCorneal Epithelial Defect

Phase 1

Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect

CompletedNCT07132437

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Corneal Diseases

Start: 2021-12-29End: 2022-05-17Updated: 2025-08-20

Phase 2

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

CompletedNCT07120308

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Corneal Epithelial Defect

Start: 2021-09-15End: 2023-01-30Updated: 2025-08-13